Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biogen Inc. stock logo
BIIB
Biogen
$251.65
-0.7%
$233.96
$160.36
▼
$261.00
$37.03B0.11.25 million shs839,661 shs
Netflix, Inc. stock logo
NFLX
Netflix
$60.75
-2.3%
$68.83
$60.48
▼
$115.25
$257.43B1.6246.15 million shs35.82 million shs
NIKE, Inc. stock logo
NKE
NIKE
$38.27
+0.7%
$36.88
$31.97
▼
$69.14
$56.09B1.0122.46 million shs18.85 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biogen Inc. stock logo
BIIB
Biogen
0.00%+2.03%+8.92%+21.16%+51.24%
Netflix, Inc. stock logo
NFLX
Netflix
0.00%-1.99%-11.88%-18.25%-44.12%
NIKE, Inc. stock logo
NKE
NIKE
0.00%-1.75%+2.21%-3.00%-40.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biogen Inc. stock logo
BIIB
Biogen
$251.65
-0.7%
$233.96
$160.36
▼
$261.00
$37.03B0.11.25 million shs839,661 shs
Netflix, Inc. stock logo
NFLX
Netflix
$60.75
-2.3%
$68.83
$60.48
▼
$115.25
$257.43B1.6246.15 million shs35.82 million shs
NIKE, Inc. stock logo
NKE
NIKE
$38.27
+0.7%
$36.88
$31.97
▼
$69.14
$56.09B1.0122.46 million shs18.85 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biogen Inc. stock logo
BIIB
Biogen
0.00%+2.03%+8.92%+21.16%+51.24%
Netflix, Inc. stock logo
NFLX
Netflix
0.00%-1.99%-11.88%-18.25%-44.12%
NIKE, Inc. stock logo
NKE
NIKE
0.00%-1.75%+2.21%-3.00%-40.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biogen Inc. stock logo
BIIB
Biogen
2.67
Moderate Buy$254.411.10% Upside
Netflix, Inc. stock logo
NFLX
Netflix
2.66
Moderate Buy$89.1446.74% Upside
NIKE, Inc. stock logo
NKE
NIKE
1.93
Reduce$40.836.69% Upside

Current Analyst Ratings Breakdown

Latest BIIB, NKE, and NFLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
NIKE, Inc. stock logo
NKE
NIKE
Reiterated RatingNeutral$38.00
11/13/2026
NIKE, Inc. stock logo
NKE
NIKE
Reiterated RatingNeutral
11/12/2026
NIKE, Inc. stock logo
NKE
NIKE
Reiterated RatingBuy$50.00
11/11/2026
NIKE, Inc. stock logo
NKE
NIKE
Reiterated RatingSector Weight
11/10/2026
NIKE, Inc. stock logo
NKE
NIKE
Initiated CoverageNeutral$38.00
11/9/2026
Biogen Inc. stock logo
BIIB
Biogen
Reiterated RatingOverweight$245.00 ➝ $305.00
11/6/2026
NIKE, Inc. stock logo
NKE
NIKE
Lower Price TargetSector Perform$40.00 ➝ $39.00
11/5/2026
NIKE, Inc. stock logo
NKE
NIKE
DowngradeHold ➝ Sell$29.00
11/2/2026
Biogen Inc. stock logo
BIIB
Biogen
Boost Price TargetBuy$280.00 ➝ $300.00
11/2/2026
Biogen Inc. stock logo
BIIB
Biogen
Boost Price TargetBuy$251.00 ➝ $270.00
10/29/2026
Biogen Inc. stock logo
BIIB
Biogen
DowngradeHold (C) ➝ Hold (C-)
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biogen Inc. stock logo
BIIB
Biogen
$9.89B3.76$22.73 per share11.07$128.01 per share1.97
Netflix, Inc. stock logo
NFLX
Netflix
$45.18B5.52$6.37 per share9.54$7.13 per share8.52
NIKE, Inc. stock logo
NKE
NIKE
$46.40B1.23$2.14 per share17.86$10.02 per share3.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biogen Inc. stock logo
BIIB
Biogen
$1.29B$2.3421.2615.792.843.37%9.38%5.69%N/A
Netflix, Inc. stock logo
NFLX
Netflix
$10.98B$3.4621.4016.240.9229.69%42.69%21.40%1/19/2027 (Estimated)
NIKE, Inc. stock logo
NKE
NIKE
$3.11B$2.0824.2026.034.336.74%15.94%6.15%12/17/2026 (Estimated)

Latest BIIB, NKE, and NFLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/28/2026Q3 2026
Biogen Inc. stock logo
BIIB
Biogen
$1.99$2.62+$0.63-$0.14$2.63 billion$2.80 billion
10/20/2026Q3 2026
Netflix, Inc. stock logo
NFLX
Netflix
$0.82$0.87+$0.05$0.87$12.87 billion$12.87 billion
10/1/2026Q1 2027
NIKE, Inc. stock logo
NKE
NIKE
$0.4331$0.48+$0.0469$0.48$11.32 billion$11.21 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biogen Inc. stock logo
BIIB
Biogen
N/AN/AN/AN/AN/A
Netflix, Inc. stock logo
NFLX
Netflix
N/AN/AN/AN/AN/A
NIKE, Inc. stock logo
NKE
NIKE
$1.644.34%+8.65%78.85%22 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biogen Inc. stock logo
BIIB
Biogen
0.39
1.95
1.37
Netflix, Inc. stock logo
NFLX
Netflix
0.43
1.07
1.07
NIKE, Inc. stock logo
NKE
NIKE
0.39
2.07
1.39

Institutional Ownership

CompanyInstitutional Ownership
Biogen Inc. stock logo
BIIB
Biogen
87.93%
Netflix, Inc. stock logo
NFLX
Netflix
80.93%
NIKE, Inc. stock logo
NKE
NIKE
64.25%

Insider Ownership

CompanyInsider Ownership
Biogen Inc. stock logo
BIIB
Biogen
0.25%
Netflix, Inc. stock logo
NFLX
Netflix
1.24%
NIKE, Inc. stock logo
NKE
NIKE
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biogen Inc. stock logo
BIIB
Biogen
7,500147.82 million147.45 millionOptionable
Netflix, Inc. stock logo
NFLX
Netflix
16,0004.11 billion4.06 billionOptionable
NIKE, Inc. stock logo
NKE
NIKE
73,0001.49 billion1.47 billionOptionable

Recent News About These Companies

Luxury Goods Stocks To Follow Now - November 16th
What's Going On With Nike Stock Today?
Cantor Fitzgerald Reaffirms "Neutral" Rating for NIKE (NYSE:NKE)
Luxury Goods Stocks To Watch Now - November 15th
NIKE: What We Expect From The Upcoming Investor Days
NIKE (NYSE:NKE) Stock Rating Reaffirmed as Buy by BTIG Research
Top Luxury Goods Stocks To Follow Now - November 13th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biogen stock logo

Biogen NASDAQ:BIIB

$251.65 -1.75 (-0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$253.00 +1.35 (+0.54%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Netflix stock logo

Netflix NASDAQ:NFLX

$60.75 -1.40 (-2.25%)
Closing price 04:00 PM Eastern
Extended Trading
$60.86 +0.12 (+0.19%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries. The company was incorporated in 1997 and is headquartered in Los Gatos, California.

NIKE stock logo

NIKE NYSE:NKE

$38.27 +0.28 (+0.73%)
Closing price 03:59 PM Eastern
Extended Trading
$38.28 +0.02 (+0.04%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.